HOFBF (Hofseth BioCare ASA) GF Value Rank: 4 (As of Jul. 21, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOFBF Hofseth BioCare ASA HOFBF
51 GF Score
Price $0.17
GF Value $0.26
! 6 Warning Signs
View Full Analysis

What is Hofseth BioCare ASA GF Value Rank?

Hofseth BioCare ASA HOFBF 51 GF Value Rank is 4 as of Jul. 21, 2026, which is at its 10-year median of 4.00. GuruFocus rates HOFBF with a GF Score™ of 51/100 and a GF Value™ of $0.26. The stock has 6 warning signs investors should review.

Hofseth BioCare ASA has the GF Value Rank of 4.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Hofseth BioCare ASA GF Value Rank Related Terms

HOFBF vs KHC, GIS, HRL: GF Value Rank Comparison

For the Packaged Foods subindustry, Hofseth BioCare ASA's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hofseth BioCare ASA GF Value Rank vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Hofseth BioCare ASA's GF Value Rank falls into.


HOFBF
51GF Score
Hofseth BioCare ASA HOFBF
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 4 mean?
Hofseth BioCare ASA (HOFBF) has a GF Value Rank of 4 as of Jul. 21, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Hofseth BioCare ASA and its competitors. This is near median its historical median of 4.00. Over the past decade, Hofseth BioCare ASA's GF Value Rank has ranged from 1.00 to 10.00.
Is Hofseth BioCare ASA's GF Value Rank too high?
Hofseth BioCare ASA's current GF Value Rank of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Hofseth BioCare ASA has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's GF Value Rank compare to KHC and GIS?
Hofseth BioCare ASA's GF Value Rank of 4 can be compared against companies in the Consumer Packaged Goods industry. Historically, Hofseth BioCare ASA's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Consumer Packaged Goods company?
A good GF Value Rank depends on the Consumer Packaged Goods industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Hofseth BioCare ASA and its competitors. Hofseth BioCare ASA's current GF Value Rank is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Hofseth BioCare ASA (HOFBF) has a current GF Value Rank of 4. The stock's GF Value™ is $0.26, compared to a current price of $0.17 — trading 35.9% below its estimated fair value. The current GF Value Rank is 4, which is near median its 10-year median of 4.00. Hofseth BioCare ASA's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Hofseth BioCare ASA (HOFBF), the current GF Value Rank is 4 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hofseth BioCare ASA (HOFBF) Overvalued in 2026?

Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued. The current stock price of $0.17 is trading 35.9% below its estimated GF Value™ of $0.26.

Key valuation signals for HOFBF:

  • GF Value Rank: 4 (near median its 10-year median of 4.00)
  • GF Value™: $0.26 vs. price of $0.17 (35.9% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the HOFBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hofseth BioCare ASA Business Description

Address Keiser Wilhelmsgate 24, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
51GF Score

Get the complete analysis for HOFBF

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.26
GF Value